Analyst Upgrades – Endocyte (NASDAQ:ECYT) Stock Gets Upgraded By Wedbush from Neutral to Outperform

ME Staff
-
0

Analyst Ratings For Endocyte (NASDAQ:ECYT)

Today, Endocyte (NASDAQ:ECYT) stock received an upgrade by Wedbush from Neutral to Outperform.

There are 1 hold rating, 2 buy ratings on the stock.

The current consensus rating on Endocyte (NASDAQ:ECYT) is Buy (Score: 2.67) with a consensus target price of $4.50 per share, a potential 23.97% upside.

Some recent analyst ratings include

  • 10/3/2017-Wedbush Upgrade from a “Neutral ” rating to a ” Outperform” rating.
  • 6/2/2017-Cowen and Company was Downgraded by analysts at Cowen and Company from a “Outperform ” rating to a ” Market Perform” rating.
  • 11/11/2016-Credit Suisse Group Reiterated Rating of Buy.

Recent Insider Trading Activity For Endocyte (NASDAQ:ECYT)
Endocyte (NASDAQ:ECYT) has insider ownership of 14.86% and institutional ownership of 28.80%.

  • On 12/30/2016 Christopher P. Leamon, VP, sold 23,244 with an average share price of $2.55 per share and the total transaction amounting to $59,272.20. View SEC Filing
  • On 5/10/2016 Philip S Low, Insider, bought 11,375 with an average share price of $3.52 per share and the total transaction amounting to $40,040.00. View SEC Filing
  • On 1/19/2016 Fred A. Middleton, Director, bought 10,000 with an average share price of $2.79 per share and the total transaction amounting to $27,900.00. View SEC Filing
  • On 1/15/2016 Fred A. Middleton, Director, bought 20,000 with an average share price of $2.80 per share and the total transaction amounting to $56,000.00. View SEC Filing
  • On 4/9/2014 Allen Ritter, VP, sold 1,000 with an average share price of $21.16 per share and the total transaction amounting to $21,160.00. View SEC Filing
  • On 3/21/2014 Allen Ritter, VP, sold 8,000 with an average share price of $33.11 per share and the total transaction amounting to $264,880.00. View SEC Filing
  • On 2/14/2014 Philip Low, Insider, sold 6,000 with an average share price of $15.00 per share and the total transaction amounting to $90,000.00. View SEC Filing

Recent Trading Activity for Endocyte (NASDAQ:ECYT)
Shares of Endocyte closed the previous trading session at with shares trading hands.